Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial (Q42990184)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 March 2013
edit
Language Label Description Also known as
English
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
scientific article published on 15 March 2013

    Statements

    Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial (English)
    David E Bernstein
    Stuart C Gordon
    Jane K Anderson
    Robert H Hyland
    Robert G Hindes
    Efsevia Albanis
    William T Symonds
    M Michelle Berrey

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit